Granite Point Capital Management, L.P. Valneva Se Transaction History
Granite Point Capital Management, L.P.
- $0
- Q3 2023
Shares
2 transactions
Others Institutions Holding VALN
# of Institutions
12Shares Held
451KCall Options Held
0Put Options Held
0-
General American Investors CO Inc354KShares$2.64 Million0.2% of portfolio
-
Alpha Centric Advisors LLC San Juan, PR62KShares$462,5490.34% of portfolio
-
Ironwood Investment Management LLC Boston, MA25KShares$186,6640.1% of portfolio
-
Morgan Stanley New York, NY5.47KShares$40,8360.0% of portfolio
-
Wells Fargo & Company San Francisco, CA2.52KShares$18,7990.0% of portfolio
About Valneva SE
- Ticker VALN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,103,504
- Market Cap $516M
- Description
- Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; ...